Skip to main content

Table 3 Multivariable regression analysis result for prediction of mortality of patients with severe COVID-19

From: The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial

 

Adjusted OR (95% CI)

P-value

IVIg (Treatment Group)

0.003 (0.001, 0.815)

0.042

Age

1.485 (1.011, 2.181)

0.044

Systolic BP

1.078 (0.924, 1.258)

0.336

Diastolic BP

0.543 (0.303, 0.972)

0.040

O2 saturation

0.841 (0.621, 1.138)

0.262

PLT

1.000 (0.999, 1.000)

0.132

LDH

1.023 (1.000,1.046)

0.048

BUN

1.136 (0.990,1.304)

0.069

Creatinine

0.018 (0.001,6.085)

0.177

PaO2

0.834 (0.593,1.173)

0.298

  1. IVIg Intravenous immunoglobulin, BP Blood pressure, LDH Lactate dehydrogenase, BUN Blood urea nitrogen, PaO2 Partial pressure of oxygen